Science

Misconduct claims may derail MDMA psychedelic treatment for PTSD

People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA, the chemical found in ecstasy. In August, the Food and Drug Administration plans to decide whether MDMA-assisted therapy for PTSD will be approved for market based on years of research. But serious allegations of research misconduct may derail the approval timeline.

NPR science reporter Will Stone talks to host Emily Kwong about the clinical trials on MDMA-assisted therapy research and a recent report questioning the validity of the results.

Read Will's full story here.

Are auroras coming back?

The same solar region that brought an outburst of night-time beauty in early May is coming back around. But things have changed, a space weather expert tells NPR.